The orthobiologics devicemaker, based in Durham, N.C., said it will pay $45 million upfront to acquire Bioness and up to $65 million more, contingent on meeting certain key milestones. It didn’t specify the milestones.
Under the agreement, Bioness will become a wholly owned subsidiary of Bioventus.
Bioventus said the total addressable market for medical devices marketed by Bioness is estimated to be more than $8 billion.
Read the full news release here.
More articles on supply chain:
US pulls 25M isolation gowns from national stockpile over safety concerns
Carcinogen found in 44 hand sanitizer brands introduced during pandemic
How Cardinal Health is using tracking technology to get a better look into its supply chain
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
